Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring γ-retrovirus-encoded hsvtk suicide genes

Gene Therapy

Volumn 15, Issue 21, 2008, Pages 1454-1459

  Wang, X ^a   Olszewska, M ^a   Capacio, V ^a   Stefanski, J ^a   Przybylowski, M ^a   Samakoglu, S ^a   Chang, A H ^a   Sadelain, M ^a   Riviere I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HERPES SIMPLEX VIRUS THYMIDINE KINASE; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOID CELL; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROVIRUS; RNA SPLICING; SUICIDE GENE; TRANSGENE; VIRUS REPLICATION; WILD TYPE;

ANTIVIRAL AGENTS; CELL LINE; CLONE CELLS; GAMMARETROVIRUS; GANCICLOVIR; GENES, TRANSGENIC, SUICIDE; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; MUTATION; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, VIRAL; SIMPLEXVIRUS; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC;

SIMPLEXVIRUS;

EID: 54549114445     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.103     Document Type: Article

References (29)

1. Pathak VK, Temin HM. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Deletions and deletions with insertions. Proc Natl Acad Sci USA 1990; 87: 6024-6028.
2. Pulsinelli GA, Temin HM. Characterization of large deletions occurring during a single round of retrovirus vector replication: Novel deletion mechanism involving errors in strand transfer. J Virol 1991; 65 4786-4797.
3. Roberts JD, Preston BD, Johnston LA, Soni A, Loeb LA, Kunkel TA. Fidelity of two retroviral reverse transcriptases during DNA-dependent DNA synthesis in vitro. Mol Cell Biol 1989; 9: 469-476.
4. Varela-Echavarria A, Prorock CM, Ron Y, Dougherty JP. High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J Virol 1993; 67: 6357-6364.
5. Parthasarathi S, Varela-Echavarria A, Ron Y, Preston BD, Dougherty JP. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: Characterization and implications. J Virol 1995; 69: 7991-8000.
6. Bonini C, Bondanza A, Perna SK, Kaneko S, Traversari C, Ciceri F et al. The suicide gene therapy challenge: How to improve a successful gene therapy approach. Mol Ther 2007; 15: 1248-1252.
7. Garin MI, Garrett E, Tiberghien P, Apperley JF, Chalmers D, Melo JV et al. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 2001; 97: 122-129.
8. Deschamps M, Mercier P, Certoux JM, Henry C, Lioure B, Pagneux C et al. Deletions within the HSV-tk transgene in longlasting circulating gene-modified T-cells infused with a hematopoietic graft. Blood 2007; 110: 3842-3852.
9. Frank O, Rudolph C, Heberlein C, von Neuhoff N, Schrock E, Schambach A et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 2004; 104: 3543-3549.
10. Blumenthal M, Skelton D, Pepper KA, Jahn T, Methangkool E, Kohn DB. Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Mol Ther 2007; 15: 183-192.
11. Gallardo HF, Tan C, Sadelain M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Therapy 1997; 4 1115-1119.
12. Chalmers D, Ferrand C, Apperley JF, Melo JV, Ebeling S, Newton I et al. Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene. Mol Ther 2001; 4: 146-148.
13. Dang Q, Hu WS. Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol 2001; 75: 809-820.
14. De Angioletti M, Rovira A, Sadelain M, Luzzatto L, Notaro R. Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors. J Virol 2002; 76: 1991-1994.
15. Riviere I, Brose K, Mulligan RC. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 1995; 92: 6733-6737.
16. Krall WJ, Skelton DC, Yu XJ, Riviere I, Lehn P, Mulligan RC et al. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Therapy 1996; 3: 37-48.
17. Wang M, Marin A. Characterization and prediction of alternative splice sites. Gene 2006; 366: 219-227.
18. ten Dam GB, Zilch CF, Wallace D, Wieringa B, Beverley PC, Poels LG et al. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol 2000; 164: 5287-5295.
19. Goren A, Ram O, Amit M, Keren H, Lev-Maor G, Vig I et al. Comparative analysis identifies exonic splicing regulatory sequences - the complex definition of enhancers and silencers. Mol Cell 2006; 22: 769-781.
20. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571.
21. Zheng ZM. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J Biomed Sci 2004; 11: 278-294.
22. Stoltzfus CM, Madsen JM. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr HIV Res 2006; 4: 43-55.
23. Griffiths A, Coen DM. An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 2005; 102: 9667-9672.
24. Duch M, Carrasco ML, Jespersen T, Aagaard L, Pedersen FS. An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo. Nucleic Acids Res 2004; 32: 2039-2048.
25. Zhang WH, Hwang CK, Hu WS, Gorelick RJ, Pathak VK. Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo. J Virol 2002; 76: 7473-7484.
26. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 1996; 93: 11400-11406.
27. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
28. Przybylowski M, Hakakha A, Stefanski J, Hodges J, Sadelain M, Riviere I. Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in cell factories. Gene Therapy 2006; 13: 95-100.
29. Nolan G. Phoenix-eco Packaging Cell Line. http://wwwstanfordedu/ group/nolan/retroviral_systems/phxhtml.